Double Medical(SZ:002901) Sou Hu Cai Jing·2026-01-22 12:17Core Viewpoint - The stock of Dabo Medical (002901) has shown a decline in price and mixed capital flow, indicating potential volatility in investor sentiment and market performance [1][3]. Group 1: Stock Performance - As of January 22, 2026, Dabo Medical's stock closed at 49.42 yuan, down 1.06% with a turnover rate of 0.58% and a trading volume of 16,800 lots, amounting to a transaction value of 83.36 million yuan [1]. - The net outflow of main funds on January 22 was 1.92 million yuan, accounting for 2.31% of the total transaction value, while retail investors saw a net inflow of 1.26 million yuan, representing 1.51% of the total [1]. Group 2: Financial Metrics and Industry Comparison - Dabo Medical's total market capitalization is 20.461 billion yuan, significantly higher than the industry average of 11.31 billion yuan, ranking 12th out of 127 companies in the medical device sector [2]. - The company reported a net profit of 425 million yuan for the first three quarters of 2025, a year-on-year increase of 77.03%, with a gross margin of 71.23%, which is well above the industry average of 50.94% [2]. - The company's return on equity (ROE) stands at 12.83%, placing it 7th in the industry, while its price-to-earnings ratio (P/E) is 36.14, significantly lower than the industry average of 97.34 [2].